TickerStat.com

Attovia Therapeutics, Inc. (ATTO)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$1.4M$0
Research & development$471,000$300,000
Operating income−$67.2M−$41.6M
Net income−$60.6M−$39.8M
Diluted EPSper diluted share-$15.42-$12.76
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗